Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer
This new plain language summary explains the results of the JAVELIN Bladder 100 study, which looked at avelumab maintenance treatment in people with advanced urothelial cancer.